National call for cancer clinical trial system to be more responsive to community needs

November 10, 2008

Milwaukee, WI -- November 10, 2008 - Addressing the nation's continuing poor performance in cancer clinical trial participation, particularly among racial and ethnic minorities and low income groups, will require meaningful public involvement in the design and implementation of clinical trials, according to a landmark report released today.

Despite many previous calls for community participation and engagement, Communities as Partners in Cancer Clinical Trials: Changing Research, Practice and Policy is the first report to define how the cancer clinical trial system can involve communities affected by cancer: from trial design - to implementation - to dissemination of research results. Among the report's 58 recommendations are calls for:

The Communities as Partners in Cancer Clinical Trials project, convened by the Education Network for Advancing Cancer Clinical Trials (ENACCT) and Community-Campus Partnerships for Health (CCPH), is funded by a core grant from the Agency for Health Care Research and Quality (AHRQ) and the National Cancer Institute. "AHRQ is proud to be a core sponsor of this initiative," said AHRQ Director, Carolyn Clancy. "We're delighted to see that two of our evidence reports provide a foundation for this 'call to action' to improve cancer clinical trial participation, especially among underserved populations."

The Lance Armstrong Foundation (LAF), another project sponsor, sees promise in the report's recommendations. "Communities as Partners builds on what we know works in other types of research - namely, engagement of patients, survivors and at-risk communities in the research process. It's what we need to do to improve clinical trial accrual and ultimately, to prevent suffering and death due to cancer," said LAF Vice President of Programs and Policy, Andy Miller.

Over a two year period, ENACCT and CCPH engaged a diverse group of stakeholders - including Federal agencies, patient advocacy and community-based organizations, cancer centers, oncology practices, health professional schools, philanthropy, the pharmaceutical industry and health care professional societies - many of whom had never before met together-- to develop the recommendations for improving patient participation rates and addressing persistent disparities in phase III cancer clinical trials.

Nancy Roach, cancer survivor and Chair, Board of Directors of C3: Colorectal Cancer Coalition, who participated in the process, sees greater community engagement in cancer clinical trials as a positive step. "Greater representation of all people affected by cancer in the clinical trial development and implementation process should lead to better outcomes and faster cures for all cancer patients."

Coinciding with the release of the report, ENACCT and CCPH are also announcing a call for "Implementation Partners," which will provide seed grant funding and technical assistance to help support implementation of the report's recommendations. Proposals are due on December 5, 2008.
The full report, report summary, and call for implementation partners are available on the project website at


The Education Network to Advance Cancer Clinical Trials' (ENACCT) is the only national organization devoted solely to implementing and evaluating clinical trial educational efforts. ENACCT's mission is to identify, implement and validate innovative community centered approaches to cancer clinical trials education. In its work, ENACCT: Develops and delivers the highest quality, evidence based, community-focused clinical trials education programs for health care providers, patients, and the public; offers high quality, fee-based services that enhance the capacity of organizations conducting cancer clinical trials outreach, education and recruitment; and advocates for the inclusion of appropriate cancer clinical trials education as a top national priority. For more information, visit


Community-Campus Partnerships for Health (CCPH) is a nonprofit organization that promotes health (broadly defined) through partnerships between communities and higher educational institutions. Founded in 1996, CCPH is a growing network of over 1,800 communities and campuses across North America and increasingly the world that are collaborating to promote health through service-learning, community-based participatory research, broad-based coalitions and other partnership strategies. These partnerships are powerful tools for improving higher education, civic engagement and the overall health of communities. CCPH advances its mission by disseminating information, providing training and technical assistance, conducting research and evaluations, developing and influencing policies, and building coalitions. The organization is based at the Medical College of Wisconsin in Milwaukee, WI. For more information, visit

Medical College of Wisconsin

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to